| Business Type | Supplier, Trader |
| Brand | Emblaveo |
| Composition | Aztreonam Avibactam Injection |
| Packaging Type | Box |
| Click to view more | |
Product Details
EMBLAVEO is the first β-lactam/β-lactamase inhibitor antibiotic combination approved in the European Union for treating serious infections in adult patients caused by multidrug-resistant Gram-negative bacteria, including metallo-β-lactamase-producing bacteria
EMBLAVEO was reviewed under European Medicines Agency accelerated assessment procedure, used when a pharmaceutical product is of major interest for public health and therapeutic innovation
Hi! Simply click below and type your query.
Our experts will reply you very soon.